Abiopharma

New Form 4 - Xencor Inc Filed: 2025-06-16 AccNo: 0001127602-25-017593 Size: 11 KB

New Form 4 - Guardant Health, Inc. Filed: 2025-06-16 AccNo: 0001576280-25-000177 Size: 10 KB

New Form 4 - Guardant Health, Inc. Filed: 2025-06-16 AccNo: 0001576280-25-000175 Size: 6 KB

New Form 4 - Xencor Inc Filed: 2025-06-16 AccNo: 0001127602-25-017590 Size: 6 KB

New Form 4 - Guardant Health, Inc. Filed: 2025-06-16 AccNo: 0001576280-25-000173 Size: 6 KB

New Form 4 - Xencor Inc Filed: 2025-06-16 AccNo: 0001127602-25-017587 Size: 11 KB

New Form 4 - Guardant Health, Inc. Filed: 2025-06-16 AccNo: 0001576280-25-000171 Size: 6 KB

PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results

New Form 4 - Tyra Biosciences, Inc. Filed: 2025-06-16 AccNo: 0000950170-25-086960 Size: 8 KB

New Form 4 - BioXcel Therapeutics, Inc. Filed: 2025-06-16 AccNo: 0001104659-25-059982 Size: 11 KB

New Form 4 - BioXcel Therapeutics, Inc. Filed: 2025-06-16 AccNo: 0001104659-25-059981 Size: 11 KB

New Form 4 - BioXcel Therapeutics, Inc. Filed: 2025-06-16 AccNo: 0001104659-25-059980 Size: 13 KB

New Form 4 - Surrozen, Inc./DE Filed: 2025-06-16 AccNo: 0001593968-25-000787 Size: 5 KB

New Form 4 - Surrozen, Inc./DE Filed: 2025-06-16 AccNo: 0001593968-25-000786 Size: 4 KB

New Form 3 - BRISTOL MYERS SQUIBB CO Filed: 2025-06-16 AccNo: 0000014272-25-000113 Size: 198 KB